SILO PHARMA INC's ticker is and the CUSIP is 82711P201. A total of 11 filers reported holding SILO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,663 | -22.9% | 6,663 | +50.3% | 0.00% | – |
| Q1 2024 | $8,642 | -14.4% | 4,432 | -36.7% | 0.00% | – |
| Q4 2023 | $10,090 | +23.6% | 7,007 | +43.3% | 0.00% | – |
| Q3 2023 | $8,166 | -17.6% | 4,890 | +1.2% | 0.00% | – |
| Q2 2023 | $9,910 | +82483.3% | 4,834 | -12.0% | 0.00% | – |
| Q1 2023 | $12 | +200.0% | 5,491 | +372.1% | 0.00% | – |
| Q4 2022 | $4 | – | 1,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Financial Advocates Investment Management | 57,507 | $117,889 | 0.01% |
| WELLS FARGO & COMPANY/MN | 21 | $43 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,542 | $49,820 | 0.00% |
| JPMORGAN CHASE & CO | 200 | $410 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,834 | $9,910 | 0.00% |
| STATE STREET CORP | 12,500 | $25,375 | 0.00% |
| Westside Investment Management, Inc. | 94 | $193 | 0.00% |